News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
147,109 Results
Type
Article (11925)
Company Profile (54)
Press Release (135130)
Section
Business (42648)
Career Advice (120)
Deals (7498)
Drug Delivery (10)
Drug Development (20384)
Employer Resources (14)
FDA (3465)
Job Trends (2916)
News (73830)
Policy (6666)
Tag
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2026 Genetown Elite (1)
Academia (774)
Accelerated approval (1)
Adcomms (5)
Allergies (6)
Alliances (14610)
ALS (23)
Alzheimer's disease (367)
Antibody-drug conjugate (ADC) (19)
Approvals (3495)
Artificial intelligence (52)
Autoimmune disease (1)
Automation (3)
Bankruptcy (25)
Best Places to Work (2582)
BIOSECURE Act (2)
Biosimilars (22)
Biotechnology (52)
Bladder cancer (11)
Brain cancer (8)
Breast cancer (51)
Cancer (470)
Cardiovascular disease (35)
Career advice (107)
Career pathing (1)
CAR-T (35)
Cell therapy (127)
Clinical research (16147)
Collaboration (256)
Compensation (76)
Complete response letters (6)
COVID-19 (776)
CRISPR (24)
C-suite (51)
Cystic fibrosis (62)
Data (554)
Depression (4)
Diabetes (36)
Diagnostics (2069)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (37)
Drug pricing (5)
Duchenne muscular dystrophy (47)
Earnings (14021)
Editorial (5)
Employer branding (3)
Employer resources (13)
Events (18615)
Executive appointments (130)
FDA (3769)
Featured Employer (13)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (164)
Gene editing (66)
Generative AI (1)
Gene therapy (166)
GLP-1 (115)
Government (776)
Grass and pollen (1)
Guidances (9)
Healthcare (3356)
Huntington's disease (7)
IgA nephropathy (6)
Immunology and inflammation (9)
Indications (8)
Infectious disease (806)
Inflammatory bowel disease (38)
Inflation Reduction Act (1)
Influenza (9)
Intellectual property (24)
Interviews (14)
IPO (3150)
IRA (2)
Job creations (512)
Job search strategy (104)
Kidney cancer (1)
Labor market (2)
Layoffs (63)
Legal (1318)
Liver cancer (23)
Lung cancer (63)
Lymphoma (39)
Management (1)
Manufacturing (60)
MASH (8)
Medical device (1437)
Medtech (1438)
Mergers & acquisitions (4498)
Metabolic disorders (109)
Multiple sclerosis (16)
NASH (2)
Neurodegenerative disease (27)
Neuropsychiatric disorders (4)
Neuroscience (510)
NextGen: Class of 2025 (951)
Non-profit (734)
Northern California (540)
Now hiring (4)
Obesity (60)
Opinion (41)
Ovarian cancer (13)
Pain (13)
Pancreatic cancer (17)
Parkinson's disease (45)
Partnered (4)
Patents (36)
Patient recruitment (16)
People (12141)
Pharmaceutical (6)
Phase I (5404)
Phase II (7185)
Phase III (5590)
Pipeline (276)
Podcasts (3)
Policy (8)
Postmarket research (463)
Preclinical (2218)
Press Release (20)
Prostate cancer (12)
Psychedelics (3)
Radiopharmaceuticals (40)
Rare diseases (197)
Real estate (1087)
Recruiting (3)
Regulatory (5104)
Reports (13)
Research institute (888)
Resumes & cover letters (11)
Rett syndrome (4)
RNA editing (3)
RSV (4)
Schizophrenia (11)
Series A (38)
Series B (18)
Service/supplier (2)
Sickle cell disease (21)
Southern California (406)
Special edition (2)
Spinal muscular atrophy (133)
Sponsored (5)
Startups (1008)
Stomach cancer (1)
Supply chain (8)
Tariffs (1)
The Weekly (3)
United States (4438)
Vaccines (130)
Venture capitalists (5)
Webinars (3)
Weight loss (14)
Women's health (3)
Date
Last 7 days (154)
Last 30 days (576)
Last 365 days (8189)
2025 (1964)
2024 (8602)
2023 (9544)
2022 (14382)
2021 (14294)
2020 (12443)
2019 (9198)
2018 (6971)
2017 (7655)
2016 (6877)
2015 (8342)
2014 (6129)
2013 (5064)
2012 (4999)
2011 (5080)
2010 (4581)
Location
Africa (174)
Alabama (5)
Alaska (2)
Arizona (22)
Arkansas (1)
Asia (23991)
Australia (3029)
California (1155)
Canada (385)
China (179)
Colorado (36)
Connecticut (52)
Delaware (12)
Europe (24220)
Florida (124)
Georgia (15)
Idaho (4)
Illinois (43)
India (11)
Indiana (81)
Iowa (1)
Japan (92)
Kansas (10)
Kentucky (4)
Louisiana (3)
Maine (6)
Maryland (201)
Massachusetts (1094)
Michigan (47)
Minnesota (34)
Missouri (5)
Montana (2)
Nebraska (5)
Nevada (9)
New Hampshire (3)
New Jersey (334)
New Mexico (3)
New York (355)
North Carolina (200)
North Dakota (4)
Northern California (540)
Ohio (36)
Oklahoma (1)
Oregon (6)
Pennsylvania (284)
Puerto Rico (1)
Rhode Island (4)
South America (222)
South Carolina (1)
Southern California (406)
Tennessee (2)
Texas (138)
Utah (79)
Virginia (44)
Washington D.C. (8)
Washington State (107)
Wisconsin (13)
147,109 Results for "oxford genetics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
March 19, 2025
·
3 min read
Press Releases
Oxford BioDynamics’ EpiSwitch® CRC Blood Test Accurately Detects both Cancer and Polyps
February 5, 2025
·
5 min read
Press Releases
Top Neuroscientist Matthew Anderson Appointed Co-Director of the Oxford-Harrington Rare Disease Centre
February 19, 2025
·
3 min read
Oxford Nanopore Technologies Collaborates With Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine
Oxford Nanopore Technologies announced the launch of a new Pharmacogenomics Beta Program to advance personalised medicine, combining Twist Bioscience’s next generation sequencing target enrichment technology with Oxford Nanopore’s sequencing platform.
May 22, 2024
·
3 min read
Press Releases
Oxford Brain Diagnostics has been granted FDA Clearance for its novel MRI Software - CDM Insights, marking a key advancement in assessing neurodegeneration for patients
January 16, 2025
·
2 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
Business
Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The Oxford Science Park to Accelerate Development of its Immuno-Oncology and ADC-Based Cancer Therapies
Oxford BioTherapeutics Ltd., a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjugate -based therapies, announced that it has relocated its UK headquarters to The Schrodinger Building within The Oxford Science Park.
October 11, 2023
·
3 min read
Business
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
Azenta, Inc. announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market.
May 13, 2024
·
3 min read
1 of 14,711
Next
